연구자 검색 | 성심산학협력단

남재환 교수

Nam, Jae-Hwan

연구분야

바이러스 면역학

연구키워드

예방용/치료용 백신 및 암 백신 연구 자가면역질환 연구 바이러스성 비만 연구

홈페이지 바로가기

교수소개

English

남재환 교수는 고려대학교 생물학과에서 학사, 석사, 박사 과정을 졸업하였고 미국 NIH에서 교환연구원 및 Visiting Fellow로 근무하였음. 이후 국립보건연구원 (現 질병관리청) 에서 보건연구관으로 근무하였으며 2005년부터 현재까지 가톨릭대학교 교수로써 근무하고 있음. 1997년부터 현재까지 미국바이러스학회 정회원이며 2011년부터 현재까지 International Journal of Obesity의 Editorial Board로 활동하고 있으며 2024년 현재 대한바이러스학회 차기회장직을 겸하고 있음. 주요 관심사로는 RNA를 면역증강제로 활용한 바이러스 백신 개발을 진행하고 있음. 또한 현재 차세대 백신 플랫폼으로써 떠오르고 있는 mRNA vaccine과 관련된 다양한 연구를 진행하고 있으며 다양한 바이러스 백신 및 암 백신 개발, mRNA 전달용 지질 전달체 개발, mRNA 백신의 면역 효과와 부작용 기전 연구 등을 수행하고 있음. 여러 편의 mRNA 관련 논문을 출판하였으며 특히 국내에서는 최초로 mRNA를 활용한 면역 항암 치료제 연구 성과를 논문으로 출판하였음. 이상의 활동을 통해 국내에서 mRNA 분야의 연구 인프라 구축과 투자 확대에 기여하고 있음.

Professor Nam Jaehwan is a faculty member in the Department of Biomedical Science at the Catholic University of Korea. He earned his bachelor's, master's, and doctoral degrees from Korea University's Department of Biology and worked at the US National Institutes of Health (NIH) as an exchange researcher and visiting fellow. Subsequently, he served as a health researcher at the National Institute of Health (now the Korea Disease Control and Prevention Agency) before joining the Catholic University of Korea as a professor in 2005. Since 1997, he has been a regular member of the American Society for Virology and has served on the Editorial Board of the International Journal of Obesity since 2011. As of 2024, he also holds the position of the next president of the Korean Society for Virology. His primary research focuses on developing virus vaccines using RNA as an immune enhancer. He is also actively involved in various studies related to mRNA vaccines, including their immune effects, side effects, and delivery mechanisms. Professor Nam has published numerous papers on mRNA-related topics and notably pioneered research on immune anti-cancer therapy using mRNA in Korea. Through his work, he contributes to expanding research infrastructure and investment in the mRNA field domestically.

최종학력

1997.08.24 | 고려대학교 | 생물학과 | 이학박사

연구실적

2024.09 | 교신저자 | SMALL, 제22권 38호, pp.2405-2405
Rational Design of Lipid Nanoparticles for Enhanced mRNA Vaccine Delivery via Machine Learning
2023.12 | 교신저자 | JOURNAL OF MEDICAL VIROLOGY, 제95권 12호
mRNA-HPV vaccine encoding E6 and E7 improves therapeutic potential for HPV-mediated cancers via subcutaneous immunization
2023.12 | 교신저자 | JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY, 제33권 12호, pp.1576-1586
The Adenylyl Cyclase Activator Forskolin Increases Influenza Virus Propagation in MDCK Cells by Regulating ERK1/2 Activity
2023.11 | 교신저자 | VACCINE, 제41권 47호, pp.7033-7033
Recombinant measles virus encoding the spike protein of SARS-CoV-2 efficiently induces Th1 responses and neutralizing antibodies that block SARS-CoV-2 variants (vol 41, pg 1892, 2023)
2023.10 | 교신저자 | NPJ VACCINES, 제8권 1호
mRNA vaccine encoding Gn provides protection against severe fever with thrombocytopenia syndrome virus in mice
2023.07 | 교신저자 | EXPERIMENTAL AND MOLECULAR MEDICINE, 제55권 7호, pp.1305-1313
<i>Knife's edge</i>: Balancing immunogenicity and reactogenicity in mRNA vaccines
2023.07 | 공동저자 | NANO LETTERS, 제23권 17호, pp.7897-7905
Microfluidic Bioreactor with Fibrous Micromixers for In Vitro mRNA Transcription
2023.06 | 교신저자 | NPJ VACCINES, 제8권 1호
Analyzing immune responses to varied mRNA and protein vaccine sequences
2023.05 | 교신저자 | SCIENTIFIC REPORTS, 제13권 1호
Heterologous vaccination utilizing viral vector and protein platforms confers complete protection against SFTSV
2022.11 | 교신저자 | MICROBIOLOGY AND IMMUNOLOGY, 제66권 11호, pp.529-537
Single-stranded RNA adjuvant enhances the efficacy of 10-valent human papilloma virus-like particle vaccine
2022.10 | 교신저자 | BMC CANCER, 제22권 1호
Adjuvant effect of IRES-based single-stranded RNA on melanoma immunotherapy
2022.01 | 교신저자 | REVIEWS IN MEDICAL VIROLOGY, 제32권 1호
Influenza vaccines: Past, present, and future
2021.09 | 교신저자 | JOURNAL OF BACTERIOLOGY AND VIROLOGY, 제51권 3호, pp.103-111
Immune responses to varicella zoster virus and effective vaccines
2021.09 | 교신저자 | FRONTIERS IN MICROBIOLOGY, 제12권
Peptides Derived From S and N Proteins of Severe Acute Respiratory Syndrome Coronavirus 2 Induce T Cell Responses: A Proof of Concept for T Cell Vaccines
2021.07 | 교신저자 | MICROBIOLOGY AND IMMUNOLOGY, 제65권 7호, pp.273-278
Next-generation sequencing for typing human papillomaviruses and predicting multi-infections and their clinical symptoms
2021.06 | 교신저자 | SCIENTIFIC REPORTS, 제11권 1호
Effective inactivated influenza vaccine for the elderly using a single-stranded RNA-based adjuvant
2021.05 | 교신저자 | SCIENCE ADVANCES, 제7권 22호
Immunization with RBD-P2 and N protects against SARS-CoV-2 in nonhuman primates
2021.03 | 교신저자 | FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 제11권
Neutralizing Antibodies to Severe Fever With Thrombocytopenia Syndrome Virus Among Survivors, Non-Survivors and Healthy Residents in South Korea
2020.09 | 교신저자 | VACCINE, 제38권 39호, pp.6141-6152
Inactivated influenza vaccine formulated with single-stranded RNA-based adjuvant confers mucosal immunity and cross-protection against influenza virus infection
2020.07 | 교신저자 | ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 제59권 28호, pp.11540-11549
Nanoformulated Single-Stranded RNA-Based Adjuvant with a Coordinative Amphiphile as an Effective Stabilizer: Inducing Humoral Immune Response by Activation of Antigen-Presenting Cells
2020.07 | 공동저자 | BIOTECHNOLOGY AND BIOENGINEERING, 제117권 7호, pp.1990-2007
Built-in RNA-mediated chaperone (chaperna) for antigen folding tailored to immunized hosts
2020.07 | 교신저자 | INTERNATIONAL JOURNAL OF OBESITY, 제44권 7호, pp.1541-1542
Insight into the relationship between obesity-induced low-level chronic inflammation and COVID-19 infection
2020.06 | 교신저자 | INTERNATIONAL JOURNAL OF OBESITY, 제44권 6호, pp.1197-1209
What we know and what we need to know about adenovirus 36-induced obesity
2020.06 | 교신저자 | ACTA VIROLOGICA, 제64권 2호, pp.251-260
Recent advances in vaccines and diagnostics against Middle East respiratory syndrome coronavirus
2020.06 | 교신저자 | JOURNAL OF BACTERIOLOGY AND VIROLOGY, 제50권 2호, pp.76-96
Lessons Learned from SARS-CoV and MERS-CoV:Preparation for SARS-CoV-2 induced COVID-19
2020.05 | 교신저자 | PHARMACEUTICS, 제12권 5호
MERS-CoV Spike Protein Vaccine and Inactivated Influenza Vaccine Formulated with Single Strand RNA Adjuvant Induce T-Cell Activation through Intranasal Immunization in Mice
2020.03 | 교신저자 | IMMUNITY, INFLAMMATION AND DISEASE, 제8권 2호, pp.216-227
Evaluation of glycoprotein E subunit and live attenuated varicella-zoster virus vaccines formulated with a single-strand RNA-based adjuvant
2020.02 | 교신저자 | JOURNAL OF BACTERIOLOGY AND VIROLOGY, 제50권 1호, pp.44-54
Evaluation of Multiplex Polymerase Chain Reaction Assay for the Simultaneous Detection of Sexually Transmitted Infections Using Swab Specimen
2019.09 | 교신저자 | PHARMACEUTICS, 제11권 9호
Comprehensive Analysis of the Safety Profile of a Single-Stranded RNA Nano-Structure Adjuvant
2019.08 | 교신저자 | VACCINE, 제37권 36호, pp.5191-5202
Cricket paralysis virus internal ribosome entry site-derived RNA promotes conventional vaccine efficacy by enhancing a balanced Th1/Th2 response
2019.07 | 공동저자 | Molecular & Cellular Toxicology, 제15권 3호, pp.245-254
Covalent conjugates of granulin-epithelial precursor-siRNA with arginine-rich peptide for improved stability and intracellular delivery in hepatoma cells
2019.01 | 교신저자 | JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY, 제29권 1호, pp.127-140
Development of an RNA Expression Platform Controlled by Viral Internal Ribosome Entry Sites
2018.12 | 교신저자 | ACTA VIROLOGICA, 제62권 4호, pp.350-359
Development of a standard protocol for quantitative polymerase chain reaction to detect adenovirus 36, which is associated with obesity
2018.09 | 교신저자 | MICROBIOLOGY AND IMMUNOLOGY, 제62권 9호, pp.574-584
Development of a diagnostic system for detection of specific antibodies and antigens against Middle East respiratory syndrome coronavirus
2018.08 | 교신저자 | JOURNAL OF MICROBIOLOGY, 제56권 8호, pp.593-599
Development and validation of multiplex real-time PCR assays for rapid detection of cytomegalovirus, Epstein-Barr virus, and polyomavirus BK in whole blood from transplant candidates
2018.07 | 교신저자 | CLINICAL AND EXPERIMENTAL VACCINE RESEARCH, 제7권 2호, pp.111-118
Evaluation of EZplex MTBC/NTM real-time PCR kit: Diagnostic accuracy and efficacy in vaccination
2018.05 | 교신저자 | VACCINE, 제36권 24호, pp.3468-3476
Heterologous prime?boost vaccination with adenoviral vector and protein nanoparticles induces both Th1 and Th2 responses against Middle East respiratory syndrome coronavirus
2018.03 | 교신저자 | MICROBIOLOGY AND IMMUNOLOGY, 제62권 3호, pp.176-186
Effect of apoptosis-associated speck-like protein containing a caspase recruitment domain on vaccine efficacy: Overcoming the effects of its deficiency with aluminum hydroxide adjuvant
2018.03 | 교신저자 | JOURNAL OF BACTERIOLOGY AND VIROLOGY, 제48권 1호, pp.1-13
Diagnosis of Viral Infection Using Real-time Polymerase Chain Reaction
2017.10 | 교신저자 | INTERNATIONAL JOURNAL OF OBESITY, 제41권 10호, pp.1601-1605
Insulin-sparing and fungible effects of E4orf1 combined with an adipocyte-targeting sequence in mouse models of type 1 and type 2 diabetes
2017.09 | 교신저자 | JOURNAL OF BACTERIOLOGY AND VIROLOGY, 제47권 3호, pp.111-121
Human Rhinoviruses: the Forgotten but Still Important Viruses
2017.08 | 교신저자 | VACCINE, 제35권 36호, pp.4687-4694
Macrophage-derived insulin-like growth factor-1 affects influenza vaccine efficacy through the regulation of immune cell homeostasis
2017.01 | 교신저자 | SCIENTIFIC REPORTS, 제7권 40280호, pp.1-10
IK acts as an immunoregulator of inflammatory arthritis by suppressing TH17 cell differentiation and macrophage activation
2017.10 | 교신저자 | JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY, 제27권 10호, pp.1892-1895
Recombinant Adeno-Associated Virus Expressing Truncated IK Cytokine Diminishes the Symptoms of Inflammatory Arthritis
2017.09 | 교신저자 | INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 제18권 9호, pp.1-15
Therapeutic Effect of Exogenous Truncated IK Protein in Inflammatory Arthritis
2016.12 | 교신저자 | MICROBIOLOGY AND IMMUNOLOGY, 제60권 12호, pp.846-853
Sublingual immunization with Japanese encephalitis virus vaccine effectively induces immunity through both cellular and humoral immune responses in mice
2016.09 | 교신저자 | JOURNAL OF BACTERIOLOGY AND VIROLOGY, 제46권 3호, pp.115-127
The Characteristics of RNA Vaccine; its Strengths and Weaknesses
2016.09 | 교신저자 | ACTA VIROLOGICA, 제60권 3호, pp.298-306
Diet-induced obesity reduces the production of influenza vaccine-induced antibodies via impaired macrophage function
2016.03 | 교신저자 | INTERNATIONAL JOURNAL OF OBESITY, 제40권 3호, pp.460-470
Characteristics of adipose tissue macrophages and macrophage-derived insulin-like growth factor-1 in virus-induced obesity
2015.12 | 교신저자 | JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY, 제25권 12호, pp.2169-2172
Tracking Study About Adenovirus 36 Infection: Increase of Adiposity
2015.12 | 교신저자 | JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY, 제25권 12호, pp.2146-2152
Apios americana Medik Extract Alleviates Lung Inflammation in Influenza Virus H1N1- and Endotoxin-Induced Acute Lung Injury
2015.11 | 교신저자 | ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY, 제40권 3호, pp.924-930
The effect of lipopolysaccharide-induced obesity and its chronic inflammation on influenza virus-related pathology
2015.09 | 교신저자 | Journal of Bacteriology and Virology, 제45권 3호, pp.179-188
Influence of the Host Factors on Human Papillomavirus Infection and Vaccine Efficacy
2015.03 | 공동저자 | Journal of Cardiovascular Ultrasound, 제23권 1호, pp.10-19
Cardiovascular Screening in Asymptomatic Adolescents with Metabolic Syndrome
2014.12 | 교신저자 | PLOS ONE, 제9권 12호, pp.114534-114534
Adenovirus 36 attenuates weight loss from exercise but improves glycemic control by increasing mitochondrial activity in the liver
2014.12 | 공동저자 | Korean Journal of Pediatrics, 제57권 12호, pp.526-532
Associations of matrix metalloproteinase (MMP)- 8, MMP-9, and their inhibitor, tissue inhibitor of metalloproteinase-1, with obesity-related biomarkers in apparently healthy adolescent boys
2014.11 | 교신저자 | INTERNATIONAL JOURNAL OF OBESITY, 제38권 11호, pp.1470-1474
Proof-of-concept for a virus-induced obesity vaccine; vaccination against the obesity agent adenovirus 36
2014.09 | 교신저자 | Journal of Bacteriology and Virology, 제44권 3호, pp.226-235
Is Obesity One of Physiological Factors which Exert Influenza Virus-induced Pathology and Vaccine Efficacy?
2014.09 | 교신저자 | JOURNAL OF GENERAL VIROLOGY, 제95권, pp.2010-2018
Coxsackievirus B3 regulates T-cell infiltration into the heart by lymphocyte function-associated antigen-1 activation via the cAMP/Rap1 axis
2014.05 | 교신저자 | HUMAN VACCINES & IMMUNOTHERAPEUTICS, 제10권 5호, pp.1181-1186
Obesity-induced chronic inflammation is associated with the reduced efficacy of influenza vaccine
2014.05 | 교신저자 | MICROBIOLOGY AND IMMUNOLOGY, 제58권, pp.303-306
Reduction of adenovirus 36-induced obesity and inflammation by mulberry extract
2014.01 | 교신저자 | CLINICAL AND EXPERIMENTAL VACCINE RESEARCH, 제3권 1호, pp.37-41
Prophylactic and therapeutic vaccines for obesity
2013.12 | 교신저자 | ACTA VIROLOGICA, 제57권, pp.462-466
Histone deacetylase inhibitors suppress coxsackievirus B3 growth in vitro and myocarditis induced in mice
2013.09 | 공동저자 | OBESITY REVIEWS, 제14권, pp.721-735
Harnessing the beneficial properties of adipogenic microbes for improving human health
2013.09 | 교신저자 | MICROBIOLOGY AND IMMUNOLOGY, 제57권, pp.660-664
Immunogenicity and safety of H1N1 influenza hemagglutinin protein expressed in a baculovirus system
2013.09 | 교신저자 | JOURNAL OF BACTERIOLOGY AND VIROLOGY, 제43권 3호, pp.229-232
Novel role of invariant natural killer T-cell in glycemic control: Regulation by human adenovirus 36
2013.05 | 제1저자 | INTERNATIONAL JOURNAL OF OBESITY, 제37권, pp.1-5
Genomic stability of adipogenic human adenovirus 36
2013.04 | 단독 | JOURNAL OF CLINICAL VIROLOGY, 제56권 4호, pp.370-371
Why is not there a match between the serological and genomic prevalence of adenovirus 36?
2013.02 | 교신저자 | VIRAL IMMUNOLOGY, 제26권 1호, pp.13-24
IK Induced by Coxsackievirus B3 Infection Transiently Downregulates Expression of MHC Class II Through Increasing cAMP
2012.12 | 교신저자 | GENE THERAPY, 제19권 12호, pp.1159-1165
Coxsackievirus B3 used as a gene therapy vector to express functional FGF2
2012.12 | 교신저자 | ACTA VIROLOGICA, 제56권 4호, pp.337-342
A peptide vaccine based on a B-cell epitope on the VP1 protein of enterovirus 70 induces a strong antibody response
2012.12 | 단독 | JOURNAL OF BACTERIOLOGY AND VIROLOGY, 제42권 4호, pp.359-362
Regulation of Obesity and Non-alcoholic Fatty Liver Diseases by Modulation of the Gut Microbiota Through Inflammasome; its Mechanism and Potential for Clinical Use
2012.10 | 공동저자 | NUTRITION RESEARCH, 제32권 10호, pp.770-777
Black soybean anthocyanins inhibit adipocyte differentiation in 3T3-L1 cells
2012.07 | 교신저자 | MICROBIOLOGY AND IMMUNOLOGY, 제56권 7호, pp.463-471
Development of an in vitro antigen-detection test as an alternative method to the in vivo plaque reduction neutralization test for the quality control of Japanese encephalitis virus vaccine
2012.03 | 교신저자 | JOURNAL OF INFECTIOUS DISEASES, 제205권 6호, pp.914-922
Adenovirus 36 as an Obesity Agent Maintains the Obesity State by Increasing MCP-1 and Inducing Inflammation
2011.12 | 공동저자 | FREE RADICAL BIOLOGY AND MEDICINE, 제51권 12호, pp.2217-2226
Chk1 and Hsp90 cooperatively regulate phosphorylation of endothelial nitric oxide synthase at serine 1179
2011.12 | 공동저자 | JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY, 제2011권 12호, pp.1-9
Transcription Factor Sp1 Is Involved in Expressional Regulation of Coxsackie and Adenovirus Receptor in Cancer Cells
2011.10 | 교신저자 | VIRUS GENES, 제44권 1호, pp.1-7
A mechanism of immunoreceptor tyrosine-based activation motif (ITAM)-like sequences in the capsid protein VP2 in viral growth and pathogenesis of Coxsackievirus B3.
2011.10 | 교신저자 | INTERNATIONAL JOURNAL OF ONCOLOGY, 제39권 4호, pp.853-861
RNA interference against granulin-epithelin precursor prevents hepatocellular carcinoma growth: Its application as a therapeutic agent
2011.09 | 교신저자 | JOURNAL OF BACTERIOLOGY AND VIROLOGY, 제41권 3호, pp.205-207
Regulation of Innate Immunity via MHC Class II-mediated Signaling; Non-classical Role of MHC Class II in Innate Immunity
2011.06 | 교신저자 | JOURNAL OF BACTERIOLOGY AND VIROLOGY, 제41권 2호, pp.123-130
Development of a Gene Therapy Method for Cervical Cancer Using Attenuated Coxsackievirus B3 as a Vector System
2011.06 | 교신저자 | JOURNAL OF BACTERIOLOGY AND VIROLOGY, 제41권 2호, pp.65-76
Infectobesity: a New Area for Microbiological and Virological Research
2011.05 | 교신저자 | INTERNATIONAL JOURNAL OF OBESITY, 제35권 1호, pp.1-6
Novel genes and cellular pathways related to infection with adenovirus-36 as an obesity agent in human mesenchymal stem cells.
2011.05 | 교신저자 | INTERNATIONAL JOURNAL OF OBESITY, 제35권 1호, pp.1-5
Association of human adenovirus-36 in overweight Korean adults.
2011.04 | 교신저자 | HUMAN VACCINES, 제7권 4호, pp.410-416
Application of attenuated coxsackievirus B3 as a viral vector system for vaccines and gene therapy
2010.11 | 교신저자 | 한국분자세포생물학회 웹진, 제2010권 11호, pp.1-8
감염성비만(Infectobesity) Do you know 'Fat Bug'?
2010.02 | 교신저자 | VACCINE, 제28권, pp.1234-1240
Systematic analysis of attenuated Coxsackievirus expressing a foreign gene as a viral vaccine vector
2010.02 | 교신저자 | EXPERT OPINION ON BIOLOGICAL THERAPY, 제10권, pp.179-190
Characterization of attenuated coxsackievirus B3 strains and prospects of their application as live-attenuated vaccines
2010.01 | 교신저자 | INTERNATIONAL JOURNAL OF OBESITY, 제34권, pp.89-93
Association between human adenovirus-36 and lipid disorders in Korean schoolchildren
2009.07 | 공동저자 | VIROLOGY JOURNAL, 제6권
The prM-independent packaging of pseudotyped Japanese encephalitis virus
2009.03 | 교신저자 | VACCINE, 제27권, pp.1974-1983
Attenuation of coxsackievirus B3 by VP2 mutation and its application as a vaccine against virus-induced myocarditis and pancreatitis
2009.11 | 단독 | EXPERT REVIEW OF VACCINES, 제8권, pp.1535-1539
Rapamycin: could it enhance vaccine efficacy?
2009.03 | 교신저자 | JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY, 제19권, pp.307-313
Systemic Analysis of a Novel Coxsackievirus Gene Delivery System in a Mouse Model
2009.03 | 공동저자 | 한국미생물.생명공학회지, 제37권 1호, pp.33-41
낙엽진흙버섯 자실체 유래 열수 추출물과 에탄올 침전물의 항바이러스활성
2008.03 | 교신저자 | ACTA VIROLOGICA, 제52권, pp.67-70
REAL-TIME RT-PCR OF HANTAAN VIRUS RNA USED FOR THE DETECTION OF VIRUS RESPONSE TO ANTIVIRAL DRUGS
2008.02 | 교신저자 | VIRUS GENES, 제36권, pp.141-146
Recombinant lentivirus-delivered short hairpin RNAs targeted to conserved coxsackievirus sequences protect against viral myocarditis and improve survival rate in an animal model
2007.11 | 교신저자 | MICROBIOLOGY AND IMMUNOLOGY, 제51권, pp.1091-1098
Production of cross-reactive peptide antibodies against viral capsid proteins of human enterovirus B to apply diagnostic reagent
2007.06 | 제1저자 | ACTA VIROLOGICA, 제51권 2호, pp.125-130
Different contribution of co-stimulatory molecules B7.1 and B7.2 to the immune response to recombinant modified vaccinia virus Ankara vaccine expressing prM/E proteins of Japanese encephalitis virus and two hepatitis B virus vaccines
2007.06 | 교신저자 | JOURNAL OF BACTERIOLOGY AND VIROLOGY, 제37권 3호, pp.161-167
Neutralizing antibody induction and cytotoxic T lymphocyte response to Nakayama-NIH and Beijing-1 as Japanese encephalitis virus vaccine strains
2007.01 | 공동저자 | VIRUS RESEARCH, 제125권, pp.9-13
Expression of short hairpin RNAs against the coxsackievirus B3 exerts potential antiviral effects in Cos-7 cells and in mice
2007.01 | 공동저자 | JOURNAL OF BACTERIOLOGY AND VIROLOGY, 제37권 1호, pp.23-30
Development of neutralization assay using murine leukemia virus (MuLV) pseudotyped with Japanese encephalitis virus (JEV) env gene
2007.12 | 공동저자 | VIRUS RESEARCH, 제130권, pp.10-17
Coxsackievirus B3 modulates cell death by downregulating activating transcription factor 3 in HeLa cells
2006.05 | 공동저자 | CARDIOVASCULAR RESEARCH, 제71권, pp.517-526
Virus receptor trap neutralizes coxsackievirus in experimental murine viral myocarditis
2006.12 | 공동저자 | JOURNAL OF BACTERIOLOGY AND VIROLOGY, 제36권 4호, pp.263-270
1996년부터 2005년까지 혈청검사로 진단된 신증후출혈열의 역학적 특성 분석
2006.07 | 교신저자 | JOURNAL OF BACTERIOLOGY AND VIROLOGY, 제36권 2호, pp.89-98
Coxsackievirus B3 H3와 10A1 감염에 의한 마우스 심장 내에서의 유전자 변이 관찰
2006.07 | 교신저자 | JOURNAL OF BACTERIOLOGY AND VIROLOGY, 제36권 2호, pp.109-118
Coxsackievirus B3의 VP2 부분에 대한 Peptide 항체 개발
2006.04 | 교신저자 | JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY, 제16권, pp.550-555
Role of protein kinase C delta in an early stage of coxsackievirus-B3-induced apoptosis in HeLa cells
2005.12.01 | 교신저자 | JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY, 제15권 6호, pp.1384-1387
Analysis of integrity of killed Hantavirus vaccine by antigen-capture reverse transcriptase PCR
2005.11.01 | 공동저자 | VIRUS RESEARCH, 제113권 2호, pp.153-157
Coxsackievirus B3 replication is related to activation of the late extracellular signal-regulated kinase (ERK) signal
2005.06.01 | 교신저자 | ACTA VIROLOGICA, 제49권, pp.91-96
The role of ERK1/2 activation in the infection of HeLa cells with human coxsackievirus B3
2005.02.01 | 교신저자 | VACCINE, 제23권, pp.1672-1679
Immunogenicity of a DNA vaccine for coxsackievirus B3 in mice: protective effects of capsid proteins against viral challenge
2005.02.01 | 공동저자 | , 제326권, pp.703-710
Retinoic acid decreases nitric oxide production in endothelial cells: a role of phosphorylation of endothelial nitric oxide synthase at Ser(1179)
2005.01.01 | 교신저자 | VIROLOGY, 제333권, pp.31-40
Internalization and trafficking mechanisms of coxsackievirus B3 in HeLa cells

2009.11.25 | 공동 | 대한미생물학회
의학미생물학 6판
2009.10 | 단독 | Springer
Encyclopedia of Molecular Mechanisms of Disease

2023.08.22 | 주발명자 | 가톨릭대학교 산학협력단
재조합 바이러스 벡터 및 이를 이용한 약학 조성물(RECOMBINANT VIRAL VECTOR AND PHARMACEUTICAL COMPOSITION INCLUIDNG THEREOF)
2021.06.08 | 주발명자 | 가톨릭대학교 산학협력단,한국과학기술연구원
안정화된 핵산 면역증강제를 함유하는 약학 조성물(PHARMACEUTICAL COMPOSTION INCLUDING STABILIZED NUCLEIC ACID ADJUVANT)
2020.02.04 | 주발명자 | 가톨릭대학교 산학협력단
바이러스성 발현 조절 서열이 삽입된 핵산 분자를 포함하는 면역보강제 및 이를 포함하는 약학 조성물(ADJUVANT COMPRISING NUCLEIC ACID MOLECULE INSERTED VIRAL EXPRESSION REGULATION SEQUENCE AND PHAMRACEUTICAL COMPOSITION HAVING THE ADJUVANT)
2019.07.31 | 주발명자 | 가톨릭대학교 산학협력단
발현 조절 서열이 삽입된 핵산 분자 및 이를 포함하는 발현 벡터(NUCLEIC ACID MOLECULES INSERTED EXPRESSION REGULATION SEQUENCES AND EXPRESSION VECTOR COMPRISING NUCLEIC ACID MOLECULES)
2018.04.17 | 주발명자 | 가톨릭대학교 산학협력단,(주)셀인바이오
아이케이 인자 및 아이케이 인자를 코딩하는 핵산의 약학적 용도
2017.08.22 | 주발명자 | 가톨릭대학교 산학협력단,셀인바이오
아이케이 인자 및 아이케이 인자를 코딩하는 핵산의 약학적 용도
2016.10.12 | 주발명자 | 가톨릭대학교 산학협력단
식물 추출물을 포함하는 천연 방부제 조성물(NATURAL ANTISEPTIC COMPOSITION HAVING PLANT EXTRACT)
2016.07.28 | 주발명자 | 가톨릭대학교 산학협력단
바이러스 증식 방법 및 그 응용(PROCESS FOR VIRAL PROLIFERATION AND APPLICATION THEREOF)
2016.05.23 | 주발명자 | 가톨릭대학교 산학협력단,(주)셀인바이오
아이케이 인자 및 아이케이 인자를 코딩하는 핵산의 약학적 용도(PHARMACEUTICAL USE OF IK FACTOR AND NUCLEIC ACIDS ENCODING IK FACTOR)
2015.11.04 | 주발명자 | 가톨릭대학교 산학협력단
티세포 활성인자로서 기능하는 콕사키바이러스 브이피2 도메인이 삽입된 재조합 벡터(RECOMBINANT VECTOR INSERTING COXSACKIEVIRUS VP2 DOMAIN FUNCTIONING AS T CELL ACTIVATOR)
2014.02.11 | 주발명자 | 가톨릭대학교 산학협력단
일본뇌염바이러스에 대한 단일클론항체, 이 항체를 생산하는 하이브리도마 세포주 및 이를 이용한 항원 검출 방법(Monoclonal Antibodies to Japanese Encephalitis Virus, Hybridoma Cell-lines of Producing the Antibodies and JEV-Antigen Detecting Method Using Thereof)
2013.09.30 | 공동발명자 | 가톨릭대학교 산학협력단
오디 유래의 감염성 비만 억제용 약학 조성물 및 건강기능식품(Pharmaceutical Composition and Functional Food for Inhibiting Obesity Caused by Infection from Mulberry)
2013.03.04 | 주발명자 | 남재환, 박기범, 정수영
엔테로바이러스 유래 질환 방지를 위한 펩타이드, 이 펩타이드를 코딩하는 핵산 및 이를 포함하는 약리학적 조성물
2013.01.30 | 주발명자 | 남재환, 박미영
그래뉼린-에피테린 전구체 유전자의발현을 억제하는 안티센스 및 이를 함유하는 약제학적 조성물
2011.11.28 | 주발명자 | 기톨릭대학교 산학협력단
엔테로바이러스 브이피2 단백질에 특이적인 단일클론항체 및 이를 생산하는 하이브리도마 세포주
2007.09.04 | 주발명자 | 가톨릭대학교 산학협력단
약독화된 콕사키바이러스게놈을 이용한 외래 유전자 발현시스템 (Expression System of Heterologous Gene using Attenuated Coxsackievirus Genome)

2023.09.27 | 주발명자 | (주)에스엠엘바이오팜
'지질 나노 입자 및 지질 화합물 기술'특허의 기술이전(양도)
2022.10.05 | 주발명자 | ㈜에스엠엘바이오팜
"면역증강제 및 핵산 의약품 전달용 지질나노입자의 약학조성물"특허의 기술이전(양도) 건
2022.09.30 | 주발명자 | ㈜에스엠엘바이오팜
“발현 효율을 증가 시킨 핵산 발현 플랫폼” 특허의 기술이전(양도)
2021.11.30 | 주발명자 | ㈜에스엠엘바이오팜
‘인플루엔자 백신과 중증혈소판감소증후군 백신’특허의 기술이전(양도) 건
2021.11.30 | 주발명자 | (주)에스엠엘바이오팜
'인플루엔자 백신과 중증혈소판감소증후군 백신'특허의 기술이전(양도) 건
2020.12.10 | 주발명자 | ㈜삼광랩트리
“재조합 바이러스 벡터 및 이를 이용한 약학 조성물” 제조기술의 기술이전
2018.11.01 | 주발명자 | ㈜이셀
‘변형된 전사 조절 서열을 가지는 핵산분자 및 이를 포함하는 발현벡터’의 기술이전 건
2018.11.01 | 주발명자 | ㈜이셀
‘RNA 백신 및 이를 이용한 Adjuvant’의 기술이전 건
2018.01.02 | 주발명자 | ㈜피토메카
“인슐린을 대체할 수 있는 폴리펩타이드,핵산 분자 및 응용” 기술의 기술이전
2017.02.10 | 주발명자 | ㈜피토메카
“바이러스성 비만 마우스 모델을 활용하여 신속/간편하게 천연물의 바이러스성 비만 억제 효과 확인 방법”의 기술이전
2017.02.10 | 주발명자 | ㈜피토메카
‘관절염 마우스 모델을 활용하여 신속/간편하게 천연물의 염증성 관절염 억제 효과 확인 방법’
2016.11.16 | 주발명자 | ㈜피토메카
“식물추출물을 이용한 항바이러스 조성물 및 면역 활성 증강 건강기능식품” 기술이전
2015.12.16 | 주발명자 | 피토메카
“식물 추출물을 포함하는 천연 방부제 조성물” 기술이전
2015.02.02 | 주발명자 | 피토메카
"애엽 발효 추출물을 함유하는 항염증 약학적 조성물 및 건강기능식품" 기술이전
2014.02.28 | 주발명자 | 셀인바이오
아이케이 인자 유래의 유전자 단편, 이 유전자 단편이 삽입된 재조합 벡터 및 이의 약학적응용 실시계약 및 특허 공동소유권 설정계약
2013.12.11 | 주발명자 | 영사이언스
티세포 활성인자로서 기능하는 콕사키 바이러스 브이피2 도메인이 삽입된 재조합 벡터 기술이전
2013.05.20 | 주발명자 | 셀인바이오
아이케이 인자 유래의 유전자 단편, 이 유전자 단편이 삽입된 재조합 벡터 및 이의 약학적응용 실시계약
2011.11.10 | 주발명자 | (주)셀인바이오
백신으로 이용 가능하도록 변형된 콕사키 바이러스의 게놈, 이 게놈이 삽입된 바이러스 벡터 및 바이러스 벡터를 포함한 백신조성물 실시계약
2009.11.06 | 주발명자 | 지엘로지스
비만을 유발하는 아데노바이러스 36 항체 진단 방법 확립

연구자현황

교수소개

최종학력

연구실적